iData Research

The global Anesthesia, Respiratory, and Sleep (ARS) market is on track to reach $19.2 billion by 2032 📈

The landscape is shifting faster than ever. Between major product recalls and legacy leaders exiting the ventilator and POC spaces, a massive competitive vacuum has opened up for innovators to step in.

Success in 2026 is about the digital monitoring and data-driven tools that are modernizing patient care both in the hospital and at home. 🏥 🏠

Whether you are tracking OSA dominance or the latest in ECMO platforms, our latest report provides the roadmap you need for the next decade.

Get the full market breakdown here: https://idataresearch.com/product/anesthesia-respiratory-and-sleep-therapy-devices-market/?utm_source=fb&utm_medium=social&utm_campaign=gl-ars

The Future of Surgery is Here!

Minimally invasive robotic surgery is transforming healthcare with greater precision, faster recovery times, and fewer complications — and the market is set to hit $30B by 2031

Discover how AI-powered robotics is shaping the next era of surgery.

Read the full 2025–2031 Surgical Robotics Market Report now on our website by clicking the link in our bio!

Discover the top 5 diabetes drugs set to transform treatment in 2025! From once-weekly insulin to innovative GLP-1 and GIP combination therapies, explore how these breakthroughs are improving outcomes, enhancing patient adherence, and reshaping diabetes care. Read the full blog now! https://zurl.co/UQolN

Let us know what you think!

📊 The Changing Landscape of Glucose Monitoring: CGM vs. FGM

The U.S. glucose monitoring market is undergoing significant changes. Continuous glucose monitoring (CGM) systems, long considered the gold standard in diabetes management, were valued at over $6 billion in 2024 and are projected to grow at a 2% CAGR, surpassing $7 billion by 2031. However, a notable shift is happening in the market—flash glucose monitoring (FGM), a more affordable alternative, has grown 45% in the past three years and is expected to nearly double by 2031.

As diabetes rates continue to rise—driven in part by increasing obesity—the demand for glucose monitoring solutions is growing. CGMs offer real-time continuous tracking, providing critical insights for patients on intensive insulin therapy. Meanwhile, FGMs provide a cost-effective option for those who do not require constant monitoring, making diabetes management more accessible.

With market leaders like Dexcom, Abbott, and Medtronic competing in the CGM space and Abbott holding a dominant position in the FGM market, the future of glucose monitoring will be shaped by both technological advancements and pricing strategies. As CGM prices decrease with innovation slowdowns, could this impact the demand for FGM?

📖 Read our latest blog for a deep dive into these emerging trends, market projections, and what this means for the future of diabetes care:https://zurl.co/kbkLU

BMAC (Bone Marrow Aspirate Concentrate) and PRP (Platelet-Rich Plasma) work to boost the body’s natural healing—helping repair joints, muscles, and tissues faster. Complimenting extremely well with bone grafting procedures!

This has caused the market to show great potential in the upcoming future!

To read more on BMAC and PRP , take a look at our new blog: https://zurl.co/fjYLH

Dental Barrier Membranes help reduce bone density loss by 25%, promoting better healing and stronger results. This has led to more dentists utilizing these barrier membranes and implementing them into more procedures.

Read more on the Dental Barrier Membrane Market on our blog: https://zurl.co/Mothg

The FDA has approved Ozempic to reduce kidney disease risks in diabetes patients, expanding its role beyond diabetes and weight management.

With this approval, Ozempic is now the most broadly indicated drug in its class, positioning Novo Nordisk for further market growth. As demand surges, we will start to see the market change!

Stay ahead with the latest medtech insights with iData Research and read more on our website: https://zurl.co/bSu5B

Surgical robots are revolutionizing the orthopedic and robotic markets. Surgical robots boast an impressive 95% success rate in procedures and are being continuously adopted by different clinics!

Read more on surgical robots and how they are impacting the markets on our newest blog post: https://zurl.co/3qNQn

Healthcare-associated infections are more common than you think. Learn more on this topic on our latest wound care press release: https://zurl.co/JeIZN

Intraoral scanners are revolutionizing dental workflows! With 53% of US dentists now using them, they’re delivering unmatched precision, efficiency, and compatibility with modern tech like clear aligners and 3D printing.

Find out more on this topic here: https://zurl.co/Ww1xl